Joerg Christian Tonn
Overview
Explore the profile of Joerg Christian Tonn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
753
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hotchkiss K, Karschnia P, Schreck K, Geurts M, Cloughesy T, Huse J, et al.
Lancet Oncol
. 2024 Oct;
25(10):e512-e519.
PMID: 39362262
Patients with brain tumours are motivated to participate in clinical trials involving repeat tissue sampling. Normalising the use of neoadjuvant and staged surgical trials necessitates collaboration among patients, regulatory agencies,...
2.
Pertz M, Schlomer S, Seidel C, Hentschel B, Loffler M, Schackert G, et al.
J Neurooncol
. 2023 Aug;
164(2):353-366.
PMID: 37648934
Purpose: Multimodal therapies have significantly improved prognosis in glioma. However, in particular radiotherapy may induce long-term neurotoxicity compromising patients' neurocognition and quality of life. The present prospective multicenter study aimed...
3.
Sarnthein J, Seidel K, Neidert M, Raabe A, Sala F, Tonn J, et al.
Clin Neurophysiol
. 2022 Aug;
142:44-51.
PMID: 35964495
Objective: During neurosurgical procedures, strip electrodes should have low impedance and sufficient adherence on the brain surface. We evaluated the signal quality, safety, and performance of a novel strip electrode...
4.
Schlomer S, Felsberg J, Pertz M, Hentschel B, Loffler M, Schackert G, et al.
J Neurooncol
. 2022 Jul;
159(1):65-79.
PMID: 35796933
Purpose: Cognitive functioning represents an essential determinant of quality of life. Since significant advances in neuro-oncological treatment have led to prolonged survival it is important to reliably identify possible treatment-related...
5.
Katzendobler S, Do A, Weller J, Dorostkar M, Albert N, Forbrig R, et al.
Front Neurol
. 2022 Apr;
13:822362.
PMID: 35432168
Background: An integrated diagnosis consisting of histology and molecular markers is the basis of the current WHO classification system of gliomas. In patients with suspected newly diagnosed or recurrent glioma,...
6.
Teske N, Karschnia P, Weller J, Siller S, Dorostkar M, Herms J, et al.
J Neurooncol
. 2021 Dec;
156(2):317-327.
PMID: 34902093
Introduction: The cIMPACT-NOW update 6 first introduced glioblastoma diagnosis based on the combination of IDH-wildtype (IDHwt) status and TERT promotor mutation (pTERTmut). In glioblastoma as defined by histopathology according to...
7.
Mollhoff N, Koban K, Engelhardt T, Tonn J, Giunta R
Handchir Mikrochir Plast Chir
. 2020 Aug;
52(4):330-334.
PMID: 32823367
This case report shows the interdisciplinary treatment of a 28-year-old woman suffering from a pronounced frontal volume defect after severe craniocerebral trauma. The combination of cranioplasty using a polymethylmethacrylate (PMMA)...
8.
Ruda R, Reifenberger G, Frappaz D, Pfister S, Laprie A, Santarius T, et al.
Neuro Oncol
. 2017 Dec;
20(4):445-456.
PMID: 29194500
Ependymal tumors are rare CNS tumors and may occur at any age, but their proportion among primary brain tumors is highest in children and young adults. Thus, the level of...
9.
Siller S, Szelenyi A, Herlitz L, Tonn J, Zausinger S
J Neurosurg Spine
. 2016 Dec;
26(4):483-493.
PMID: 27982764
OBJECTIVE Spinal cord hemangioblastomas are rare benign tumors developing either sporadically or as part of von Hippel-Lindau (VHL) disease. Generally, resection is the treatment of choice. However, the significance of...
10.
Kunz M, Nachbichler S, Ertl L, Fesl G, Egensperger R, Niyazi M, et al.
Cancer Med
. 2015 Dec;
5(3):442-53.
PMID: 26714663
To analyze efficacy, functional outcome, and treatment toxicity of low-dose rate I-125 brachytherapy (SBT) alone or in combination with best safe resection (in case of larger tumor volumes) as first-line...